Best Stocks: Oracle (NYSE:ORCL), Barrick Gold (NYSE:ABX), Viggle Inc. (NASDAQ:VGGL), REX American Resources Corporation (NYSE:REX), Bluelinx Holdings Inc. (NYSE:BXC)

The state of Oregon filed a lawsuit against Oracle Corporation (ORCL), in Marion County Circuit Court in Salem, seeking $200 million in damages from the tech company for failing to provide a functional health insurance exchange website. The state has also accused Oracle of making false statements and claims regarding the website. Oracle Corporation (NYSE:ORCL) belongs to Technology sector. Its net profit margin is 28.60% … Continue reading Best Stocks: Oracle (NYSE:ORCL), Barrick Gold (NYSE:ABX), Viggle Inc. (NASDAQ:VGGL), REX American Resources Corporation (NYSE:REX), Bluelinx Holdings Inc. (NYSE:BXC)

Big Movers: Synacor (NASDAQ:SYNC), Silicon Laboratories (NASDAQ:SLAB), Beacon Roofing Supply (NASDAQ:BECN), Video Display Corporation (NASDAQ:VIDE), Ametek Inc. (NYSE:AME)

On 12 AUG Synacor, Inc. (NASDAQ:SYNC) announced its financial results for the second quarter of 2014. For the second quarter of 2014, total revenue was $24.2 million, compared to $26.7 million in the second quarter of 2013. Search and display advertising revenue was $18.5 million, compared to $21.4 million in the second quarter of 2013. Subscription-based revenue was $5.7 million, compared to $5.3 million in … Continue reading Big Movers: Synacor (NASDAQ:SYNC), Silicon Laboratories (NASDAQ:SLAB), Beacon Roofing Supply (NASDAQ:BECN), Video Display Corporation (NASDAQ:VIDE), Ametek Inc. (NYSE:AME)

Today’s Hot List: NovaBay Pharmaceuticals (NYSEMKT:NBY), IHS (NYSE:IHS), Solitario Exploration (NYSEMKT:XPL), CIRCOR International, (NYSE:CIR), Hersha (NYSE:HT)

On July 31,2014 NovaBay Pharmaceuticals, Inc. (NYSE MKT:NBY), a biopharmaceutical company focusing on the development and commercialization of its non-antibiotic anti-infectives, today reported second quarter 2014 financial results and provided a clinical and commercialization update. NovaBay Pharmaceuticals, Inc. (NYSEMKT:NBY) belongs to Healthcare sector. Its weekly performance is 22.55%. On last trading day company shares ended up $1.25. NovaBay Pharmaceuticals, Inc. (NYSEMKT:NBY) distance from 50-day simple … Continue reading Today’s Hot List: NovaBay Pharmaceuticals (NYSEMKT:NBY), IHS (NYSE:IHS), Solitario Exploration (NYSEMKT:XPL), CIRCOR International, (NYSE:CIR), Hersha (NYSE:HT)

Morning Buzz: Activision Blizzard (NASDAQ:ATVI), Altria (NYSE:MO), Tofutti Brands (NYSEMKT:TOF), Karyopharm Therapeutics, Inc. (NASDAQ:KPTI), ICICI Bank Ltd. (NYSE:IBN)

Activision Blizzard, Inc. (NASDAQ: ATVI) reported Q2 EPS of $0.06, $0.04 better than the analyst estimate of $0.02. Revenue for the quarter came in at $658 million versus the consensus estimate of $607.75 million. Activision Blizzard, Inc. (NASDAQ:ATVI) belongs to Technology sector. Its net profit margin is 29.10% and weekly performance is -2.61%. On last trading day company shares ended up $22.36. Activision Blizzard, Inc. (NASDAQ:ATVI) … Continue reading Morning Buzz: Activision Blizzard (NASDAQ:ATVI), Altria (NYSE:MO), Tofutti Brands (NYSEMKT:TOF), Karyopharm Therapeutics, Inc. (NASDAQ:KPTI), ICICI Bank Ltd. (NYSE:IBN)

Momentum Stocks: Amazon.com (NASDAQ:AMZN), Pfizer Inc. (NYSE:PFE), Sykes Enterprises (NASDAQ:SYKE), Fluor (NYSE:FLR), Cellular Dynamics International (NASDAQ:ICEL)

Amazon.com Inc. (NASDAQ:AMZN) and Hachette Book Group are entering the fourth month of a standoff over a new e-book contract. If another publisher’s experience is any guide, the dispute could drag on. Kensington Publishing Corp., a small New York book publisher, said it recently struck a new deal for physical and digital books with Amazon. Amazon.com Inc. (NASDAQ:AMZN) belongs to Services sector. Its net profit … Continue reading Momentum Stocks: Amazon.com (NASDAQ:AMZN), Pfizer Inc. (NYSE:PFE), Sykes Enterprises (NASDAQ:SYKE), Fluor (NYSE:FLR), Cellular Dynamics International (NASDAQ:ICEL)

St. Jude Announces Consistent Q3 Results

St. Jude Medical released third-quarter performance that was generally consistent with our expectations, and we have not altered our projections for the full year.  However, we plan to modestly raise our fair value estimate to reflect the reduced share count and cash flow realized since our last update. While St. Jude continues to wrestle with a lackluster implantable cardioverter defibrillator market, we still think the … Continue reading St. Jude Announces Consistent Q3 Results